Recent investment activity

KANDO id: 40115

Corporate information

Registration country

Fund terms

Fund manager
Fund type

Funding rounds

Fund Closing CAD 65,000,000


USD 54,230,000 ( )

Profile Country


Investment activity status
Active investor

Selected investments

Displaying 1 - 4 of 4
Profile Country Date Funding
Sigvion Capital Series B
Aerpio Therapeutics Inc Series A
Altair Therapeutics Inc Developing novel therapeutics to treat human respiratory diseases. Series B Repeat investment.
Altair Therapeutics Inc Developing novel therapeutics to treat human respiratory diseases. Series A

Current team

Past employees

Selected Products / Customers

Financials